NCT04646707View on ClinicalTrials.gov

Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

NARecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

December 17, 2025

Study Completion Date

December 30, 2025

Conditions
PostoperativePain
Interventions
DRUG

Erector Spinae (ESP) Block with Lidocaine/Bupivacaine

Bilateral ESP block at T1 level with 20 ml of 1:1 mixture (2% Lidocaine: 0.5% bupivacaine)

DRUG

Erector Spinae (ESP) Block with placebo

Bilateral ESP block at T1 level with 20 ml of 0.9% normal saline

Trial Locations (1)

M5T 2S8

RECRUITING

Toronto Western Hospital?UHN, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER